Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial
Lasers in Medical Science · 15.01.2025 · 40 (1)
DOI: 10.1007/s10103-025-04293-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Lasers in Medical Science, online erschienen am 15.01.2025. Verfasst von Ghasem Rahmatpour Rokni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. Hauptthemen laut MEDLINE: Vitiligo, Lasers, Gas, Ultraviolet Therapy, Low-Level Light Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Vitiligo is a chronic depigmenting condition that causes amelanotic macules and patches on the skin. Despite various treatment options, treating vitiligo is a challenge. This study aimed to evaluate the combination of laser CO2 fractional and narrow-band ultraviolet B (NB-UVB) versus NB-UVB monotherapy in vitiligo patients. This was a prospective, self-controlled, and randomized trial. Ten patients with symmetrical vitiligo lesions on both sides of their body and who had a history of insufficient response to conventional therapies were included in this trial. Group A received three sessions of fractional CO2 laser at 1-month intervals during NB-UVB phototherapy which was performed three times a week for three months. Patients in group B only received phototherapy same as group A. The primary endpoint was the repigmentation rate. The mean age was 34.40 ± 11.93 years (range of 19-63). After the intervention, repigmentation was better in group A and the difference was statistically significant (P = 0.025). Patients in group A showed a better reduction of VASI score than group B (39.12 ± 27.81 Vs. 44.45 ± 30.77), although it was not statistically significant (P = 0.518). VETF and VIDA outcomes were slightly better in Group A than B, but it was not statistically significant (P = 0.317 and P = 0.180, respectively). The results of this study indicated that combining fractional CO2 laser with NB-UVB is superior to NB-UVB monotherapy, providing a promising modality in vitiligo patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
- Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Dermatology, Mazandaran University of Medical Sciences, Sari, Iran.
- Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Department of Dermatology, Antimicrobial Resistance Research Center, Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Zitieren
APA
Rokni, G. R., Malekan, M., Azade, S., Beyzaee, A. M., Heydari, K., Fallah, S., Kazeminejad, A., Zaresharifi, S., & Gholizadeh, N. (2025). Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial. Lasers in Medical Science, 40(1). https://doi.org/10.1007/s10103-025-04293-2
Vancouver
Rokni GR, Malekan M, Azade S, Beyzaee AM, Heydari K, Fallah S, et al. Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial. Lasers in Medical Science. 2025;40(1). doi:10.1007/s10103-025-04293-2
BibTeX
@article{Rokni2025,
author = {Rokni, Ghasem Rahmatpour and Malekan, Mohammad and Azade, Sepide and Beyzaee, Amir Mohammad and Heydari, Keyvan and Fallah, Sahar and Kazeminejad, Armaghan and Zaresharifi, Shirin and Gholizadeh, Nasim},
title = {Fractional CO2 laser combined with narrow-band ultraviolet B (NB-UVB) phototherapy versus NB-UVB monotherapy in vitiligo patients: prospective, self-controlled, and randomized trial},
journal = {Lasers in Medical Science},
year = {2025},
volume = {40},
number = {1},
doi = {10.1007/s10103-025-04293-2}
}
EUVIMED